Log in

NYSE:MEDMedifast Stock Price, Forecast & News

-1.02 (-0.62 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $163.42
50-Day Range
MA: $150.66
52-Week Range
Now: $163.42
Volume264,039 shs
Average Volume295,210 shs
Market Capitalization$1.93 billion
P/E Ratio25.53
Dividend Yield2.75%
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, franchise weight loss clinics, and direct consumer marketing. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Read More
Medifast logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products



Sales & Book Value

Annual Sales$713.67 million
Cash Flow$5.95 per share
Book Value$9.03 per share


Net Income$77.92 million


Market Cap$1.93 billion
Next Earnings Date11/5/2020 (Estimated)
-1.02 (-0.62 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Medifast (NYSE:MED) Frequently Asked Questions

How has Medifast's stock been impacted by COVID-19 (Coronavirus)?

Medifast's stock was trading at $70.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MED shares have increased by 132.0% and is now trading at $163.42.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Medifast?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Medifast

When is Medifast's next earnings date?

Medifast is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Medifast

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) posted its quarterly earnings data on Wednesday, August, 5th. The specialty retailer reported $1.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.84 by $0.12. Medifast had a return on equity of 69.77% and a net margin of 10.04%.
View Medifast's earnings history

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Tuesday, June 16th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $1.13 per share on Thursday, August 6th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date is Monday, June 29th.
View Medifast's dividend history

What price target have analysts set for MED?

4 Wall Street analysts have issued twelve-month price objectives for Medifast's shares. Their forecasts range from $86.00 to $220.00. On average, they anticipate Medifast's stock price to reach $132.00 in the next twelve months. This suggests that the stock has a possible downside of 19.2%.
View analysts' price targets for Medifast

Has Medifast been receiving favorable news coverage?

Headlines about MED stock have trended very positive recently, according to InfoTrie. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Medifast earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave news coverage about the specialty retailer a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term.
View the latest news about Medifast

Are investors shorting Medifast?

Medifast saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 1,830,000 shares, a drop of 39.2% from the June 30th total of 3,010,000 shares. Based on an average trading volume of 284,500 shares, the days-to-cover ratio is currently 6.4 days. Currently, 16.3% of the shares of the company are sold short.
View Medifast's Current Options Chain

Who are some of Medifast's key competitors?

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Boeing (BA), Mastercard (MA), Micron Technology (MU), AbbVie (ABBV), Adobe (ADBE), Paypal (PYPL) and Baidu (BIDU).

Who are Medifast's key executives?

Medifast's management team includes the following people:
  • Mr. Daniel R. Chard, CEO & Director (Age 54)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 57)
  • Mr. William Baker IV, Exec. VP of Information Technology (Age 47)
  • Mr. Nicholas Johnson, Exec. VP of Coach Success Market Pres of OPTAVIA USA (Age 39)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48)

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Who are Medifast's major shareholders?

Medifast's stock is owned by a number of retail and institutional investors. Top institutional investors include Principal Financial Group Inc. (1.68%), Ingalls & Snyder LLC (0.45%), Robeco Institutional Asset Management B.V. (0.40%), WINTON GROUP Ltd (0.36%), Chickasaw Capital Management LLC (0.26%) and Russell Investments Group Ltd. (0.24%). Company insiders that own Medifast stock include Carl E Sassano, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Michael A Hoer, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends for Medifast

Which major investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, SG Americas Securities LLC, Bridge City Capital LLC, First Trust Advisors LP, Chickasaw Capital Management LLC, Matisse Capital, Nisa Investment Advisors LLC, and MBM Wealth Consultants LLC. Company insiders that have sold Medifast company stock in the last year include Michael C Macdonald, and Scott Schlackman.
View insider buying and selling activity for Medifast

Which major investors are buying Medifast stock?

MED stock was purchased by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Mackay Shields LLC, Robeco Institutional Asset Management B.V., Russell Investments Group Ltd., Parallel Advisors LLC, Icon Advisers Inc. Co., Arizona State Retirement System, and Spearhead Capital Advisors LLC. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Jeffrey J Brown, and Michael A Hoer.
View insider buying and selling activity for Medifast

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $163.42.

How big of a company is Medifast?

Medifast has a market capitalization of $1.93 billion and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis. Medifast employs 420 workers across the globe.

What is Medifast's official website?

The official website for Medifast is www.medifast1.com.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.